detect early-stage cancer with high precision and accuracy
Blood drawn at a centralized/provider’s location and to be sent for processing and analysis
Using our propriety technology the process sample is analyzed and characterized
Within the day of the analysis, the results are electronically sent to the provider and patients for review
Your health. Made clear.
Our cutting-edge solution instills fresh hope for early intervention and improved outcomes across a wide range of cancers, including colon, ovarian, lung, and breast.
Presently, these cancer types are frequently detected at advanced stages, significantly restricting treatment choices and impacting survival rates. However, with our groundbreaking approach, we strive to rewrite this narrative, offering renewed hope for saving countless lives.
Our Strengths
Technological breakthrough
Our revolutionary test is the sole and original method that analyzes single extracellular vesicles found abundantly in the blood, even during the initial stages of cancer.
Ability for early detection
Extracellular vesicles are tiny markers that offer valuable information about the biology of the cells they come from. These markers are used for diagnosis and can provide important insights about cancer.
A team of experts
Our founders are both scientists and doctors who have assembled a diverse group of experts dedicated to a common goal: saving lives and reducing suffering through early cancer detection.